You are here: Homepage Sectorfocus Life Sciences
Life Sciences
Meest recente
1 naar 10 van 344
-
Video Podcast
Ingediend: 18 June 2013
Simmons & Simmons partner Peter Meyer talks with colleague Nicholas Fox about bifurcation in patent proceedings in Germany and the proposed Unified Patent Court.
This article forms part of our Unified Patent Court Toolkit.
-
Artikel
Ingediend: 17 June 2013
The increasing availability of mobile health smartphone software applications in the UK represents a significant shift in the way healthcare organisations can administer, and patients can access, medical treatment.
-
Artikel
Ingediend: 14 June 2013
The US Supreme Court has ruled in Association for Molecular Pathology et al v Myriad Genetics et al that isolated DNA sequences may not be patented.
-
Artikel
Ingediend: 14 June 2013
The Court of Appeal's recent judgment in Mid Essex Hospital Services NHS Trust v Compass Group UK and Ireland Ltd (t/a Medirest) [2013] EWCA Civ 200 has brought welcome guidance on contractual obligations of good faith.
-
Artikel
Ingediend: 12 June 2013
Kevin Mooney, for many years on the European Commission’s Expert Panel, and more recently Chairman of the Drafting Committee responsible for the Court’s Rules of Procedure, gives a personal view of the new Unified Patents Court.
This article forms part of our Unified Patent Court Toolkit.
-
Artikel
Ingediend: 04 June 2013
What are the practical considerations for patent proprietors in relation to the Unified Patent Court?
This article forms part of our Unified Patent Court Toolkit.
-
Nieuwsbrief
Laatst gecontroleerd: 04 June 2013 / Ingediend: 04 June 2013
China proposes to expand the categories of foreigners' visas in China and impose stricter rules to address illegal employment of foreigners in the PRC.
-
Seminar
Ingediend: 22 May 2013
How can Asian financial institutions and corporates take advantage of the European funding revolution, which offers new opportunities to Asian banks, issuers and investors?
-
Artikel
Ingediend: 22 May 2013
The long awaited decree implementing transparency obligations for the life sciences and healthcare industries has now been published.
-
Artikel
Ingediend: 02 May 2013
Eli Lilly’s alleged violation of the Foreign Corrupt Practices Act of 1977, in connection with the activities of its subsidiaries.
1 naar 10 van 344